Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Trastuzumab × Clear all

NCT00004163 2017-04-18

Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer

Phase 2 Completed

Head and Neck Neoplasms, Salivary Gland Neoplasms